Abstract:Background & Aims: The CD47-signal regulatory protein alpha (SIRP alpha) axis inhibits dendritic cell (DC) phagocytosis and contributes to immune evasion. However, the behaviour of DCs and the potential crosstalk between DCs and natural killer (NK) cells in the hepatocellular carcinoma (HCC) microenvironment after CD47 blockade remain unclear. Methods: The infiltration of CD103(+) DCs and NK cells were analysed by immunohistochemistry and immunofluorescence in both human and murine HCC specimens. An orthotopic liver tumour model was used to evaluate the function of the CD103(+) DC-NK cell axis after CD47 blockade in vivo in wild-type, Rag1(-/-) Batf3(-/-), and STING1(-/-) mice. Phagocytosis assays were performed in CD103(+) DC and HCC cell lines. CD103(+) DC-derived cytokines were analysed by chemokine array. Spleen-derived NK cells in C57BL/6J mice were used to evaluate cytotoxic functions in vitro. Results: Higher CD47 expression was associated with worse prognosis in patients with HCC. CD47 blockade enhanced antitumour efficacy by stimulating the CD103(+) DC-NK cell axis. The hypoxic microenvironment promoted CD47 blockade-induced tumour DNA phagocytosis by CD103(+) DCs. By releasing IL-12 and CXCL9, activated CD103(+) DCs induced the recruitment of NK cells with upregulated expression of granzyme B, NKG2D, interferon-gamma, and tumour necrosis factor-alpha and downregulated expression of NKG2A. The antitumour effects of CD47 blockade could be abolished by cyclic GMP-AMP synthase (cGAS)-STING pathway inhibition. Conclusions: In addition to the classical DC-T cell axis, CD47 blockade significantly enhanced the ability of CD103(+) DCs to take up tumour DNA, resulting in the stimulation of the cGAS-STING pathway, which promoted the infiltration and activation of NK cells in liver cancer. Lay summary: Hypoxia (low oxygen levels) is prevalent in the hepatocellular carcinoma microenvironment and promotes the phagocytosis (ingestion and elimination) of tumour DNA by CD103(+) dendritic cells (a type of immune cell). Blockade of the cell surface protein CD47 resulted in activation of CD103(+) dendritic cells which led to the recruitment and activation of natural killer cells (a different immune cell). When activated, these cells exhibit an antitumour effect. (C) 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

CD47-SIRPα axis restricts the therapeutic antitumor immunity through controlling tumor mitochondrial DNA-mediated innate sensing selectively in dendritic cells

Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming Through Signal Regulatory Protein Α Signaling.

CD47 Masks Pro-Phagocytic Ligands in Cis on Tumor Cells to Suppress Antitumor Immunity

CD47 Blockade Triggers T Cell–mediated Destruction of Immunogenic Tumors

CD47/SIRPα pathway mediates cancer immune escape and immunotherapy

Insights into CD47/SIRPα Axis-Targeting Tumor Immunotherapy

Blocking CD47 promotes anti-tumor immunity through CD103+ dendritic cell-NK cell axis in murine hepatocellular carcinoma model

The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy

DNA sensing via STING regulates autoimmunity and tumor immunity. (IRM5P.648)

Blocking CD47 Promotes Antitumour Immunity Through CD103+ Dendritic Cell-Nk Cell Axis in Murine Hepatocellular Carcinoma Model.

Is CD47 an Innate Immune Checkpoint for Tumor Evasion?

C-106 Tumor Targeting Antibodies to Improve Tumor Immunity: the Role of Microbiota

Regulation of CD47 expression by interferon-gamma in cancer cells

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors

Metabolic reprograming mediated by tumor cell-intrinsic type I IFN signaling is required for CD47-SIRPα blockade efficacy

Cd47-Sirpα Interaction and IL-10 Constrain Inflammation-Induced Macrophage Phagocytosis of Healthy Self-Cells.

Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment

STING Licensing of Type I Dendritic Cells Potentiates Antitumor Immunity

Intratumoral Accumulation of Gut Microbiota Facilitates CD47-based Immunotherapy Via STING Signaling

Disruption of CD47-SIRPα signaling restores inflammatory function in tumor-associated myeloid-derived suppressor cells